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A number of serological tests measuring the presence of Helicobacter pylon-specific serum immunoglobulin
G (IgG) are now commercially available. The aim of this study was to evaluate the clinical accuracy of five
commercial H. pylon antibody tests: GAP-IgG (Biomerica), HELpTEST (AMRAD, Kew, Victoria, Australia),
HELICO-G (Porton Cambridge), Pyloriset (Orion Diagnostica), and ROCHE (Roche Diagnostics). A total of
162 subjects presenting for routine upper endoscopy were studied. H. pylori was diagnosed if culture, histology,
or both were positive. Ten milliliters of venous blood was collected at the time of endoscopy for serological
assessment. The sensitivity and specificity of each test (GAP-IgG, HELpTEST, HELICO-G, Pyloriset, and
ROCHE) were as follows: 83 and 79%, 92 and 77%, 86 and 65%, 89 and 56%, and 98 and 69%, respectively.
Positive and negative predictive values were 97 and 83%, 90 and 91%, 76 and 83%, 68 and 84%, and 86 and
97%, respectively. The specificity of most tests increased by approximately 10% when sera from subjects less
than 45 years old were examined. The number of sera falling into the grey zone for each test (an indeterminate
result with respect to H. pylori status) varied between 2.5 and 19%. This study highlights the need for all
serological kits to be independently evaluated on the population to be studied by testing against a
microbiologically defined panel of H. pylori-positive and -negative sera.
Helicobacterpylori is the causative agent of type B active
chronic gastritis (2, 3), and there is increasing evidence to
support a pathogenic role in duodenal ulcer disease (8). The
current "gold standard" tests for diagnosing H. pylon infec-
tion involve histological staining and/or culture of antral
biopsy specimens (1). However, these methods are invasive,
and alternative, noninvasive methods such as the urea
breath test and serological tests are available (6). Various
serological methods have been employed, including the
complement fixation test, the bacterial agglutination test, the
passive hemagglutination test, the hemagglutination assay,
immunoblotting techniques, and enzyme-linked immunosor-
bent assays (ELISAs) (7). All of these techniques have
demonstrated a correlation between the titers or level of
reactivities and the presence of H. pylon in the gastric
antrum. A number of different serological tests to determine
H. pylon infection are now commercially available and are
being used routinely in diagnostic laboratories. The aim of
this study was to evaluate the clinical accuracy of five
commercial H. pylon antibody tests, HELpTEST (AMRAD,
Kew, Victoria, Australia), GAP-IgG (Biomerica), HE-
LICO-G (Porton Cambridge), Pyloriset (Orion Diagnostica),
and ROCHE (Roche Diagnostics), against a well-docu-
mented panel of 162 subjects diagnosed as either positive or
negative for H. pylon infection.
(The results of this study were presented in part at the
Fourth Workshop on Gastroduodenal Pathology and Helico-
bacterpylori, Bologna, Italy, 28 to 30 November, 1991.)
MATERIALS AND METHODS
Subjects. Serum samples were collected from 190 consec-
utive subjects presenting for upper endoscopy because of
upper gastrointestinal symptoms. Endoscopic diagnoses in-
cluded gastric ulcer (4.8%), duodenal ulcer (9%), gastric
erosion (22.4%), reflux esophagitis (28%), and non-ulcer
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dyspepsia (35.2%). No subject had undergone previous
gastroduodenal surgery or had taken antibiotics or bismuth
preparations within the previous three months. Twenty-eight
samples could not be tested with all five kits owing to an
insufficient volume of sample, leaving a total of 162 subjects
in the study. Blood samples were collected at the time of
endoscopy and stored at -20°C until assayed. Approval for
the study was obtained from the Monash Medical Centre
Human Ethics Committee.
H. pylori assessment. H. pylon status was assessed by
culture and histology (6). Diagnosis of H. pylon infection
was made if culture, histology, or both were positive. H.
pylon-negative subjects were negative for both tests.
For culture, one antral biopsy was transported to the
laboratory in 0.1 ml of sterile saline and processed within 3
h. It was finely minced in approximately one drop of saline,
and about a quarter of this homogenate was pressed firmly
between two glass microscope slides, one of which was
Gram stained.
The remainder of the sample was cultured on chocolate
(horse blood) agar (Columbia agar, Oxoid no. CM331) and
on brain heart infusion agar (Oxoid no. CM375) supple-
mented with 7% horse blood, 3 ,ug of vancomycin per ml, 50
,ug of nalidixic acid per ml, and 5 ,ug of trimethoprim per ml.
The plates were incubated for up to 7 days in a humid
atmosphere of 5% oxygen-10% carbon dioxide-85% nitro-
gen.
Isolates were considered to be H. pylon if they grew as
0.5- to 1-mm translucent greyish colonies after 3 days on
chocolate (horse blood) agar and were gram-negative curved
or S-shaped rods which were positive for oxidase, catalase,
and urease. Growth occurred under microaerophilic condi-
tions but not in air.
For histological analysis, one antral biopsy was fixed in
10% neutral buffered formalin and processed. Histological
staining with hematoxylin and eosin and with modified
Giemsa stain of antral biopsies was performed. Histological
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gastritis was defined as chronic inflammatory change with or
without activity (6).
H. pylori antibody tests. The HELpTEST, GAP-IgG, HE-
LICO-G, and ROCHE ELISA evaluated in this study were
of conventional design comprising the absorption and immo-
bilization of antigen onto the wells of a 96-well microtiter
plastic plate to capture H. pylori antibodies from sera that
are then detected with an anti-human immunoglobulin G
(IgG) coupled to horseradish peroxidase (HRPO), followed
by reaction with a chromogenic enzyme substrate, tetrame-
thylbenzidine. The Pyloriset test is a latex agglutination test
for the rapid detection of H. pylon antibodies in serum. H.
pyloni antigen is incorporated into the latex reagent, and
when this is added to a drop of diluted serum the agglutina-
tion of latex particles is indicative of the presence of H.
pylon antibodies.
Each test was carried out, and its results were interpreted,
according to the manufacturer's instructions. All tests ex-
cept HELICO-G used a grey-zone region, which was an
indeterminate result with respect to H. pylon status. Sensi-
tivity was defined as the ability of the test to detect a H.
pylon-positive specimen. Likewise, specificity was defined
as the ability of the test to detect a H. pylon-negative
specimen. The test results of specimens within the grey
zones were excluded from sensitivity and specificity calcu-
lation. Positive and negative predictive values reflect the
likelihood of a specimen identified as positive or negative
being a H. pylon-positive or -negative specimen as defined
by gold standard tests.
(i) HELpTEST. In the HELpTEST, each plate contained
four negative and four positive control samples (provided by
the manufacturer). Serum specimens were diluted 1:200 (5 ,u1
of sample and 1 ml of specimen diluent), with 100 ,ul being
added to each well. After incubation for 30 min at 37°C, each
plate was washed six times with the wash buffer provided
(approximately 250 ,ul per well per wash). After being dried,
100 ,ul of freshly prepared HRPO-IgG conjugate reagent was
added to each well, and the plates were incubated for 30 min
at 37°C. After repeat washings, 100 ,ul of freshly prepared
substrate reagent was added to each well and the plates were
incubated in the dark for 30 min at room temperature.
Stopping solution (100 ,ul) was then added to each well to
terminate the enzymatic reaction. The absorbance was read
within 10 min with a 450-nm filter, with a 615- to 620-nm filter
as the reference.
The cutoff value for the assay was calculated by multiply-
ing the mean of the positive controls by 0.1 (lower cutoff) or
0.3 (upper cutoff). Values falling in between this range were
regarded as intermediate (grey-zone) results. Both positive
and negative controls were used to ensure that all reagents
were working properly. The sensitivity and specificity of the
test were claimed by the manufacturer to be 92 and 86%,
respectively.
(ii) GAP-IgG test. In the GAP-IgG test, each plate con-
tained three negative and four positive control samples
(provided by the manufacturer). Serial twofold dilutions
were made with the positive control. Serum specimens were
diluted 1:200 (25 ,ul of sample and 5 ml of specimen diluent),
with 100 p,l being added to the wells in duplicate. After
incubation for 1 h at room temperature, each plate was
washed three times with the wash buffer provided (approx-
imately 250 ,ul per well per wash). After being dried, 100 ,ul
of HRPO-IgG conjugate reagent (exact volume not specified)
was added to each well and the plates were incubated for 1
h at room temperature. After repeat washings, 100 p,l of
freshly prepared substrate reagent (exact volume not speci-
fied) was added to each well and the plates were incubated in
the dark for 30 min at room temperature. Fifty microliters of
stopping solution (exact volume not specified by the manu-
facturer) was then added to each well to terminate the
enzymatic reaction. The A405 was read within 10 min against
an air blank. The readings were expressed as positive/
negative ratios by subtracting the mean negative control
reading from the mean sample reading and then dividing this
value by the mean negative control reading.
The cutoff value and grey zone for the assay were deter-
mined from the serial twofold dilutions of the positive
control. Both positive and negative controls were used to
ensure that all reagents were working properly. The sensi-
tivity and specificity of the test were claimed by the manu-
facturer to be 78 and 86%, respectively.
(iii) HELICO-G test. In the HELICO-G test, each plate
contained two positive control samples (calibrator sera pro-
vided by the manufacturer contained 10 U of specific anti-
body per ml). Serum specimens were diluted 1:200 (5 ,ul of
sample and 1 ml of specimen diluent), with 100 ,ul being
added to the wells in duplicate. After incubation for 1 h at
37°C, each plate was washed three times with the wash
buffer provided (approximately 250 p1 per well per wash).
After being dried, 100 ,ul of freshly prepared HRPO-IgG
conjugate reagent was added to each well and the plates
were incubated for 30 min at 37°C. After repeat washings,
100 ,ul of freshly prepared substrate reagent was added to
each well and the plates were incubated in the dark for 30
min at room temperature. Stopping solution (50 p,l) was then
added to each well to terminate the enzymatic reaction. The
A450 was read within 10 min against an air blank.
The 10-U/ml calibrator serum positive control was used to
determine the cutoff value of the assay. Mean sample
absorbance readings greater than this value were considered
positive for H. pylon infection. The sensitivity and specific-
ity of the test were claimed to be 93 and 91%, respectively.
(iv) Pyloriset. In the Pyloriset test, positive and negative
controls were provided by the manufacturer. Serum speci-
mens were diluted 1:2 (25 ,ul of sample and 25 ,ul of specimen
diluent), and 40 ,ul was pipetted onto one circle of the test
card. One drop of the latex reagent was then added to the
circle containing the diluted serum sample, and the droplets
were mixed. The test slide was tilted and rotated in a circular
motion for 3 min, during which time evidence for agglutina-
tion was observed.
The result was positive when agglutination was detected in
the test circle within 3 min and negative if no agglutination
was detected. The test is highly subjective and thus was
carried out by one person, with the results being interpreted
according to a scale ranging from 3+ to -. A grey zone (+)
was incorporated owing to the nature of the test. Positive
and negative controls were run along with each test sample
to monitor the performance of the test reagent. The sensi-
tivity and specificity of the test were claimed by the manu-
facturer to be 92.8 and 78.8%, respectively.
(v) ROCHE test. In the ROCHE test, each plate contained
three negative control samples and one positive control
sample (provided by the manufacturer). Serum specimens
were diluted 1:101 (10 ,ul of sample and 1 ml of specimen
diluent), with 100 p,l being added to each well. After incu-
bation for 30 min at 37°C, each plate was washed four times
with the wash buffer provided (approximately 250 ,ul per well
per wash). After being dried, 100 p1l of freshly prepared
HRPO-IgG conjugate reagent was added to each well and the
plates were incubated for 30 min at 37°C. After repeat
washings, 100 p.l of freshly prepared substrate reagent was
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TABLE 1. Summary of endoscopy findings: histology, serology, and culture results
No. of subjects No. of subjects seropositive/total no. (%)' by: No. of subjects
Endoscopy with histologic culture
diagnosis gastritis/total positive/total
no. (%) GAP-IgG HELp HELICO-G Pyloriset ROCHE no. (%)
Normal 40/61 (66) 29/57 (51) 29/47 (62) 37/63 (59) 36/52 (69) 42/60 (70) 29/61 (48)
Esophagitisb 11/22 (50) 3/16 (19) 3/16 (19) 10/22 (45) 7/17 (41) 7/22 (32) 5/22 (23)
Gastritisb 19/32 (59) 14/30 (47) 14/30 (47) 16/32 (50) 20/29 (69) 16/30 (53) 12/32 (36)
Gastric 7/7 (100) 5/6 (83) 6/6 (100) 7/7 (100) 6/6 (100) 7/7 (100) 7/7 (100)
ulcer
Duodenal 13/14 (93) 13/15 (87) 11/12 (92) 11/14 (79) 11/14 (79) 13/14 (93) 13/14 (93)
ulcer
Duodenitisb 17/26 (65) 14/24 (58) 12/20 (60) 17/26 (65) 13/22 (57) 17/25 (68) 14/26 (54)
a Grey-zone results were excluded.
b Edema, erythema, or erosions.
added to each well and the plates were incubated in the dark culture positive), one was intermediate in the GAP-IgG test,
for 10 min at room temperature. Stopping solution (100 ,ul) one was negative in the GAP-IgG test and intermediate in the
was then added to each well to terminate the enzymatic Pyloriset test, and the remaining five were positive in all
reaction. The absorbance was read within 10 min with a tests.
450-nm filter against a reagent blank. The serology results for the total 162 subjects are shown in
The cutoffvalue for the assay was calculated by adding 0.2 Table 2. When the less-than-45-year-old age group subpop-
to the mean value of the absorbances of the negative ulation was examined, the specificity and positive predictive
controls. The grey zone was calculated as +10% of this value of most tests increased by approximately 10%, while
value. Both positive and negative controls were used to the sensitivity and negative predictive value did not change
ensure that all reagents were working properly. The sensi- significantly (Table 3).
tivity and specificity of the test were claimed to be 95 and Complete agreement was observed between the gold stan-
97%, respectively. dard tests and all serological kits in 43% (69/162) of sera (45
positive and 24 negative). Disagreement between gold stan-
RESULTS dard tests and more than one serological kit was found in
sera from 57 subjects (16 positive and 41 negative). Thirteen
In total, 162 subjects presenting for routine upper endos- sera from H. pylon-negative subjects were positive by four
copy were studied. The mean age of this group was 48 years or more serological kits.
(range, 16 to 86 years), with a male-to-female ratio of 70:92. H. pylon was identified in 77 of 80 positive subjects by
These values remained similar when the population group histology. In the 13 subjects found positive by four or more
was divided into H. pylon-positive and -negative subjects. serological kits, H. pylon was not detected by culture or
A summary of the endoscopic findings with reference to histology. Chronic active inflammation was observed in four
histology, serology, and culture results is presented in Table subjects negative by culture or histology. This would suggest
1. Of the total 162 subjects, 80 were positive for H. pylon by that H. pylon was not identified by culture or histology
culture or histology. Of the 13 culture-positive duodenal owing to technical reasons or that recent eradication or
ulcer subjects, one was negative in the Pyloriset test only, clearance of the bacteria had occurred.
one was negative in the HELICO-G test and intermediate
(±) in the HELpTEST, and the other was positive only in
the ROCHE test. The remaining 10 culture-positive duode- DISCUSSION
nal ulcer subjects were positive in all tests. The one culture- In this study we have evaluated the clinical accuracy of
negative duodenal ulcer subject was also negative in all five commercially available diagnostic tests for H. pylon.
serological tests. Of the seven gastric ulcer subjects (all Subjects were considered positive for H. pylon only if
TABLE 2. Serology results for the total population (n = 162)
Serological result for subjects with:
Assay H. pylon present' H. pylon absent'
No. No. No. Sensitivity PPVd No. No. No. Specificity NPVe
GAP-IgG 63 4 13 83% 81% 15 10 57 79% 81%
HELp 60 15 5 92% 80% 15 16 51 77% 91%
HELICO-G 69 NA 11 86% 70% 29 NA 53 65% 83%
Pyloriset 62 10 8 89% 67% 31 12 39 56% 83%
ROCHE 78 0 2 98% 77% 24 4 54 69% 96%
a Positive by culture or histology.
b Negative by culture and histology.
c Grey zone. NA, not applicable.
d ppV, positive predictive value.
' NPV, negative predictive value.
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TABLE 3. Serology results for the less-than-45-year-old age group (n = 78)
Serological result for subjects with:
Assay H. pylon present' H. pylon absent"
No. No. No. ppVd No. No. No.
+
_
C Sensitivity' Pv + _f- - Specificity NPVe
GAP-IgG 29 2 7 81% 97% 1 6 33 97% 83%
HELp 28 7 3 90% 90% 3 8 29 91% 91%
HELICO-G 32 NA 6 84% 76% 10 NA 30 75% 83%
Pyloriset 28 6 4 88% 68% 13 6 21 62% 84%
ROCHE 37 0 1 97% 86% 6 2 32 84% 97%
a Positive by culture or histology.
b Negative by culture and histology.
c Grey zone. NA, not applicable.
d PpV, positive predictive value.
eNPV, negative predictive value.
culture, histology, or both were positive and were consid-
ered negative if both tests were negative. In this way we
have attempted to reduce the number of false-negative
subjects in the negative population group.
Each of the tests evaluated had the manufacturers' quoted
sensitivities and specificities well above those determined in
this study. The sensitivity and specificity of a particular test
is highly dependent upon the population group examined.
The vast differences in H. pylon prevalence among different
ethnic groups may account for this, and it may be that cutoff
values need to be readjusted for different populations.
The performance of the kits evaluated in this study was
comparable to that of others reported in the literature (both
commercial and in-house ELISAs). The type of antigen
preparation used (either crude or purified) did not produce
any significant differences in the overall results. Interest-
ingly, the ROCHE kit had quite a low specificity despite its
use of a purified antigen. A recent study by Hoek and
colleagues comparing four commercially available kits found
low specificities of the Pyloriset, GAP-IgG, and HELICO-G
tests (4).
Thirteen of the sera from H. pylon-negative patients were
positive by four or more of the kits. It is most likely that the
serology results for these patients were correct and could be
explained by either past or recently acquired infection. In
addition, sampling problems from the antral mucosa may
occur when areas of intestinal metaplasia are biopsied,
giving a false-negative result. It would be of interest to
follow up this group of patients with a 14C- or 13C-urea
breath test.
The use of a grey zone was incorporated into all tests
except for HELICO-G. The number of sera whose readings
fell into this grey zone varied according to the test used and
ranged from 2.5 to 19% of the total number of samples. This
area of uncertainty appears to be a problem for all serolog-
ical tests and is an area where further attention is required.
In general, it was found that titers falling into the grey zone
of one test also fell in or close to the grey zone of another
test.
The correlation between H. pylon infection and seropos-
itivity was greater in the less-than-45-year-old age group.
The specificity of most tests improved approximately 10%
when only this age group was examined. Reduced immuno-
logical responses in the elderly have been reported (5), and it
is therefore important to consider age profiles when assess-
ing the accuracy of serological kits. These findings differ
from those of other studies, which show lower sensitivities
and predictive values in subjects younger than 45 years (4).
The explanation for these differences is unclear.
The use of serology as a diagnostic tool for the detection of
H. pylon infection presents itself as a rapid and noninvasive
technique. Our comparison of five commercially available
serological kits has revealed most to have greater than 80%
positive and negative predictive values in subjects less than
45 years of age. All serological kits need to be independently
evaluated on the population to be studied by testing them
against a microbiologically defined panel of H. pyloni-posi-
tive and -negative sera. On the basis of this study, serology
with the appropriate kit of choice offers a noninvasive,
convenient, and inexpensive technology applicable to epide-
miological studies and in the diagnosis of H. pylon infection.
In choosing a serological kit one must consider cost, ease
of use, sample numbers to be tested, and diagnostic accu-
racy.
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